Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco D Tiziano

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|February 23, 2011
Biomarkers in rare disorders: the experience with spinal muscular atrophyFrancesco D Tiziano, Giovanni Neri, Christina Brahe
Orphanet Journal of Rare Diseases|November 4, 2011
Spinal muscular atrophyAdele D'Amico, Eugenio Mercuri, Francesco D Tiziano, et al.
AIDS Research and Therapy|September 27, 2006
Partial protective effect of CCR5-Delta 32 heterozygosity in a cohort of heterosexual Italian HIV-1 exposed uninfected individualsEnrico M Trecarichi, Mario Tumbarello, Katleen de Gaetano Donati, et al.
Annals of Clinical and Translational Neurology|November 4, 2020
Nusinersen in type 0 spinal muscular atrophy: should we treat?Eloisa Tiberi, Simonetta Costa, Marika Pane, et al.
European Journal of Human Genetics : EJHG|November 4, 2004
Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patientsChristina Brahe, Tiziana Vitali, Francesco D Tiziano, et al.
The American Journal of Pathology|August 25, 2007
Refined characterization of the expression and stability of the SMN gene productsJérémie Vitte, Coralie Fassier, Francesco D Tiziano, et al.
European Journal of Human Genetics : EJHG|October 16, 2003
Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophyCatia Andreassi, Carla Angelozzi, Francesco D Tiziano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2014
Imatinib-Sensitizing KIT Mutation in a Carney-Stratakis-Associated GI Stromal TumorDaniela Gasparotto, Sabrina Rossi, Domenico Campagna, et al.
Neuromuscular Disorders : NMD|January 22, 2004
Pilot trial of phenylbutyrate in spinal muscular atrophyEugenio Mercuri, Enrico Bertini, Sonia Messina, et al.
Annals of Neurology|January 27, 2006
Apoe epsilon2-epsilon4 genotype is a possible risk factor for primary progressive aphasiaAdele Acciarri, Carlo Masullo, Alessandra Bizzarro, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|February 23, 2011
Biomarkers in rare disorders: the experience with spinal muscular atrophyFrancesco D Tiziano, Giovanni Neri, Christina Brahe
Orphanet Journal of Rare Diseases|November 4, 2011
Spinal muscular atrophyAdele D'Amico, Eugenio Mercuri, Francesco D Tiziano, et al.
AIDS Research and Therapy|September 27, 2006
Partial protective effect of CCR5-Delta 32 heterozygosity in a cohort of heterosexual Italian HIV-1 exposed uninfected individualsEnrico M Trecarichi, Mario Tumbarello, Katleen de Gaetano Donati, et al.
Annals of Clinical and Translational Neurology|November 4, 2020
Nusinersen in type 0 spinal muscular atrophy: should we treat?Eloisa Tiberi, Simonetta Costa, Marika Pane, et al.
European Journal of Human Genetics : EJHG|November 4, 2004
Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patientsChristina Brahe, Tiziana Vitali, Francesco D Tiziano, et al.
The American Journal of Pathology|August 25, 2007
Refined characterization of the expression and stability of the SMN gene productsJérémie Vitte, Coralie Fassier, Francesco D Tiziano, et al.
European Journal of Human Genetics : EJHG|October 16, 2003
Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophyCatia Andreassi, Carla Angelozzi, Francesco D Tiziano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2014
Imatinib-Sensitizing KIT Mutation in a Carney-Stratakis-Associated GI Stromal TumorDaniela Gasparotto, Sabrina Rossi, Domenico Campagna, et al.
Neuromuscular Disorders : NMD|January 22, 2004
Pilot trial of phenylbutyrate in spinal muscular atrophyEugenio Mercuri, Enrico Bertini, Sonia Messina, et al.
Annals of Neurology|January 27, 2006
Apoe epsilon2-epsilon4 genotype is a possible risk factor for primary progressive aphasiaAdele Acciarri, Carlo Masullo, Alessandra Bizzarro, et al.
Pageof 2